" The underpinnings of belief among patients, payers, even investors, is that somebody out there has tested these things and has shown, with some evidence, that they work," he said. Mr. O’Neill did not respond to emails and a phone call requesting comment, and Dr. Gottlieb declined to comment. Dr. Gulfo, the former biotech executive, said he had spoken with several people on the president’s transition team about the F. D. A. job. 